Innovation and excellence in science and health

New appointment bolsters Cambridge Biomedical Campus expansion

Plans to further expand the real estate offer at Cambridge Biomedical Campus have been strengthened by Cambridge University Health Partners’ (CUHP) appointment of Araminta Ledger as Director of Campus Development.

Araminta’s new role will see her working closely with joint developers, Liberty Property Trust and Countryside, to promote the Campus’ ongoing expansion and attract new organisations to Phase 2 of its development.  Liberty and Countryside are currently growing the site by 90 acres to 170 acres overall, with planning consent granted in autumn 2017 for 75,000 sqm of space for clinical and science-related organisations.

Joining from the University of Cambridge’s School of Clinical Medicine, Araminta will use her extensive knowledge of the healthcare and biomedical sectors to identify organisations in keeping with the strategic aims of the Campus, where research is focused on addressing global healthcare challenges to drive real-world benefits for patients.  Core development themes include oncology, medtech and improving the use of data in healthcare research.

Unlike a traditional science park, Cambridge Biomedical Campus brings together academics, businesses and clinicians on a single site, co-locating organisations from across the life sciences to accelerate research and inform the focus of investment through face-to-face interactions.

Current occupiers benefiting from this collaborative approach include two NHS Trusts, GlaxoSmithKline, the University of Cambridge School of Clinical Medicine and the Nobel Prize-winning Medical Research Council Laboratory of Molecular Biology.  Construction is also underway at the campus for AstraZeneca’s global corporate headquarters and research and development centre, as well as the new Royal Papworth Hospital, a state-of-the-art facility for heart and lung treatments.

Andrew Blevins, Managing Director of Liberty Property Trust, said: “Growing the UK’s £64 billion life sciences industry is at the forefront of the Government’s plans to drive economic prosperity and productivity, and Cambridge Biomedical Campus is shovel-ready to deliver the advanced facilities needed to underpin this vision.  I’m confident that with Araminta’s support, the site will continue to attract the brightest minds, co-locating global life sciences leaders and healthcare professionals to drive medical breakthroughs.”

Araminta Ledger, Director of Campus Development for CUHP, said: “I am very much looking forward to working with our partners across the site and further afield to continue the exciting development of the Cambridge Biomedical Campus.  We are in a unique position where researchers, clinicians and industry are able to work together in one place – this close collaboration allows new ideas, techniques and treatments to develop which can only benefit patients here and across the UK. ”

Cambridge University Health Partners is one of six Academic Health Science Centres in England whose mission is to improve patient healthcare by bringing together the NHS, industry and academia.

Bidwells, Savills and Creative Places are acting for the developers.